YELITZA SILVA: Open Payments
NPI 1497244610 · PLANTATION, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$853 in 36 payments from 18 companies in 2025. Trend: 2023 $376 · 2024 $347 · 2025 $853
Food & beverage: $853
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $92 |
| RECORDATI_RARE_DISEASES_INC. | 3 | $88 |
| SANOFI-AVENTIS U.S. LLC | 3 | $77 |
| Dexcom, Inc. | 3 | $68 |
| Mannkind Corporation | 2 | $66 |
| Tandem Diabetes Care, Inc. | 3 | $64 |
| Corcept Therapeutics | 3 | $63 |
| Lilly USA, LLC | 3 | $60 |
| Sequel Med Tech, LLC | 2 | $41 |
| Xeris Pharmaceuticals, Inc. | 2 | $40 |
Products named: ISTURISA, TZIELD, Dexcom G6 Transmitter, AFREZZA, Ozempic, t:slim X2 Insulin Pump with Control-IQ, Korlym, MOUNJARO.
Industry payments across FL — which companies pay providers there.
